Recurrent Low Back Pain
12
1
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
25%
3 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive
B Vitamin Supplementation to Chiropractic Management of Chronic LBP: Pilot Clinical Trial (VCLBP)
Changing Trunk Muscle Activation in Patients With Recurrent Low Back Pain in Remission
Chiropractic Maintenance Care of Persistent or Recurrent Low Back Pain
Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)
Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
Pain Inhibition and Facilitation in Recurrent Low Back Pain
Mixed Reality Gaming for Chronic Low Back Pain
Yoga vs. Education for Veterans With Chronic Low Back Pain
Effects of a Mechanical Needle Stimulation Pad on Chronic Low Back Pain
Specific Stabilization Exercise With Ultrasound Feedback For Patient With Recurrent Low Back Pain